We formalize an inverse, data-conditioned variant of the Variational Quantum Eigensolver (VQE) for clinical biomarker discovery. Given patient-encoded quantum states, we construct a task-specific Hamiltonian whose coefficients are inferred from clinical associations and interpret its expectation value as a calibrated energy score for prognosis and treatment monitoring. The method integrates coefficient estimation, ansatz specification with basis rotations, commuting-group measurements, and a practical shot budget analysis. Evaluated on public infectious disease datasets under severe class imbalance, the approach yields consistent gains in balanced accuracy and precision–recall over strong classical baselines, with stability across random seeds and feature ablations. This variational energy scoring framework bridges Hamiltonian learning and clinical risk modeling, offering a compact, interpretable, and reproducible route to biomarker prioritization and decision support.
We formalize an inverse, data-conditioned variant of the Variational Quantum Eigensolver (VQE) for clinical biomarker discovery. Given patient-encoded quantum states, we construct a task-specific Hamiltonian whose coefficients are inferred from clinical associations and interpret its expectation value as a calibrated energy score for prognosis and treatment monitoring. The method integrates coefficient estimation, ansatz specification with basis rotations, commuting-group measurements, and a practical shot budget analysis. Evaluated on public infectious disease datasets under severe class imbalance, the approach yields consistent gains in balanced accuracy and precision–recall over strong classical baselines, with stability across random seeds and feature ablations. This variational energy scoring framework bridges Hamiltonian learning and clinical risk modeling, offering a compact, interpretable, and reproducible route to biomarker prioritization and decision support.
The variational quantum eigensolver (VQE) was at first designed as a hybrid quantum-classical method for finding the ground-state energies of molecules on noisy intermediate-scale quantum (NISQ) devices. Currently, however, there is a small but emerging line of research that takes the opposite approach: instead of minimizing the energy of a Hamiltonian which is derived from physical principles, the quantum state is determined according to an encoding of the patient’s clinical record, and the algorithm searches for a Hamiltonian whose ground state most closely matches that state. The resulting operator is regarded as a sparse and interpretable biomarker, and the expectation value of this operator is used as a calibrated clinical risk score. In this article, we examine this data-conditioned, or inverse, VQE approach. We begin by reiterating the standard VQE formalism, then restate the inverse objective along with its analytic solution for single-term Pauli Hamiltonians as given in the source. Additionally, we analyze the encoding, coefficient inference, measurement, and thresholding elements essential for a complete pipeline. A recent multi-qubit study involving a cohort with co-infection of HIV and tuberculosis is analyzed in detail as the most advanced example of this approach. We compare it with other related methods based on quantum kernels, variational quantum classifiers, and quantum-enhanced feature selection, and we place it within the current classification of quantum-enhanced biomarker discovery, where it does not belong in any of the existing categories. We then carry out a critical evaluation of the paradigm. The classical eigenvalue calculation within the search loop has an asymptotic scaling of O(8N), although at the two qubits that are actually used it is negligible. By restricting the search to single-term Pauli operators, it becomes possible to classically simulate the quantum expectation values, thereby nullifying the claims of quantum advantage while still preserving interpretability. The benefits reported are based on small, severely imbalanced, single-center cohorts and include no external validation or actual implementation on real hardware. Compared with the requirements that the quantum computing community is now moving towards for benchmark definitions, the published evaluation still does not yet satisfy most of the criteria currently proposed for application-level benchmarking, mainly because the classical and quantum contributions to the result are never separated. We conclude with a roadmap that specifies the particular conditions, from an evaluation-theoretic point of view, under which data-conditioned Hamiltonian learning could become a real application of quantum computing in precision medicine, before turning to algorithmic aspects.
Optimizing personalized cancer treatment plans that combine chemotherapy, radiation, and immunotherapy presents a complex challenge due to the need to balance efficacy with minimizing side effects across diverse patient profiles. This study introduces a novel hybrid quantum-classical framework leveraging the Variational Quantum Eigensolver (VQE) for multi-modal optimization. Treatment planning is formulated as a parameterized Hamiltonian, where the ground state corresponds to an optimal therapy regimen tailored to individual genomic and clinical data. The quantum VQE algorithm estimates ground state energy via quantum simulators, while classical optimizers iteratively refine circuit parameters. Benchmarking on synthetic datasets demonstrates that the hybrid approach enhances treatment personalization and computational efficiency over classical methods. Although current quantum hardware constraints limit immediate deployment, our findings validate the potential for quantum-enhanced optimization in clinical oncology. This research lays foundational groundwork for integrating near-term quantum algorithms into medical decision-making, with promising implications for improving cancer treatment outcomes and patient quality of life.
Healthcare decision support demands models that are accurate on heterogeneous clinical data, fast enough for the point of care, and transparent enough to earn clinician trust. Classical learners meet parts of this brief but struggle to capture the high-order correlations that bind physiological variables together, and they typically expose little of their internal reasoning. This paper introduces QIDSS, a quantum-inspired machine-learning framework that runs entirely on commodity classical hardware yet borrows the mathematical machinery of quantum computation—amplitude encoding, parameterised unitary evolution, and entanglement-style feature interaction—to enrich the representation of clinical evidence. A patient record is mapped into a normalised state vector, a shallow variational circuit emulated through tensor operations transforms that state, and a Born-rule measurement yields a calibrated risk estimate together with a per-feature attribution. Training proceeds by a parameter-shift gradient over the emulated circuit, combined with cross-entropy and an entanglement-regularisation term that discourages spurious correlations. We evaluate the framework on a consolidated clinical dataset and benchmark it against logistic regression, gradient-boosted trees, a deep neural network, and a simulator-based variational quantum classifier. QIDSS reaches 94.5% accuracy with matching gains in precision and recall while holding average decision latency to 9.2 ms, comfortably below the quantum baseline. Beyond the headline numbers, the framework surfaces the features that most influenced each verdict and routes low-confidence cases to clinician review. Implementation overhead, qubit-count scaling, and deployment constraints are examined candidly.
Abstract Quantum computing has emerged as a powerful tool for modeling molecular systems with high accuracy, accelerating the search for novel therapeutic targets. In this study, we present a two-stage hybrid workflow that combines a Quantum Graph Neural Network with a Variational Quantum Eigensolver to identify potent serine neutralizers in the QM9 dataset. In the first stage, an advanced quantum graph neural network architecture incorporating attention layers, self-distillation, and an adaptive learning-rate schedule is trained to predict ionization potentials and binding free energies. Across five independent random-seed trials, our adaptive-thresholded QGNN–VQE pipeline achieves an average R2 R 2 of 0.990±0.008 0.990 ± 0.008 and a mean absolute error of 0.034±0.001 0.034 ± 0.001 eV ( ≈0.79±0.03 ≈ 0.79 ± 0.03 kcal/mol) on the QM9 validation set, demonstrating robust, chemical-accuracy-level predictions. Building on these high-precision predictions, the second stage employs a QAOA-inspired hybrid ranking scheme that merges quantum graph neural network outputs, feature-space similarity (via and cosine similarity), and variational quantum eigensolver-derived energy stability. This α α -weighted ( α=0.95 α = 0.95 ) scoring framework is applied to over 133,000 molecules, efficiently parsed in parallel. The final ranked list is validated through an improved bijection test, featuring an adaptive similarity threshold to ensure both structural and functional robustness. The top-scoring candidate identified by our pipeline is 5,6,7-tetrahydro-4 H-pyrazolo[4,3-c]pyridin-4-one, highlighting the efficacy of quantum-enhanced modeling in pinpointing complex pharmacological targets. These findings underscore the transformative potential of hybrid quantum-classical workflows in drug discovery, offering a flexible blueprint for advanced screening of other critical biomolecular interactions in the rapidly expanding field of quantum biology. GraphicAbstract VQE for Serine Neutralization
Cardiovascular disease (CVD) remains a major global health challenge, necessitating advanced predictive models for early detection and risk assessment. This paper presents a quantum-enhanced machine learning framework for multi-modal cardiac biomarker analysis. The model integrates quantum feature encoding with a deep learning-based classification pipeline. Multi-modal data from imaging, electrophysiological signals, and genetic biomarkers are mapped into quantum-enhanced feature spaces using Cirq. These transformed features are then fed into a hybrid quantum-classical neural network (QNN) to improve prediction accuracy. The proposed approach is benchmarked against classical machine learning methods such as Support Vector Machines (SVM) and Random Forest (RF). Results show the potential of quantum computing in advancing precision medicine by leveraging high-dimensional feature transformations.
Asthma remains a prevalent chronic respiratory disorder characterized by complex pathophysiological mechanisms and heterogeneous clinical manifestations. Accurate and timely diagnosis is critical for mitigating disease progression and optimizing patient outcomes. Conventional machine learning approaches often struggle with high-dimensional biomedical datasets, where redundant or irrelevant features can obscure discriminative patterns and degrade predictive performance. In this study, we propose a hybrid quantum-classical learning framework for asthma diagnosis that integrates Quantum Approximate Optimization Algorithm (QAOA)-based feature selection with a Variational Quantum Classifier (VQC) using angle embedding. The publicly available Asthma Disease Dataset from Kaggle, comprising demographic, lifestyle, environmental, and clinical variables, serves as the evaluation benchmark. The QAOA module exploits quantum parallelism, superposition, and entanglement to identify an optimal subset of predictive features, achieving an average dimensionality reduction of 73.3%. The selected features are subsequently encoded into quantum states and classified by a multi-layer VQC with chain entanglement. Simulations were conducted on a noiseless Pennylane default.qubit backend to assess the theoretical performance ceiling. Experimental results demonstrate that the proposed pipeline achieves an accuracy of 98.4%, surpassing classical baselines such as SVM, Random Forest, and MLP, while maintaining competitive precision, recall, and F1-scores. These findings underscore the potential of hybrid quantum-classical architectures for high-dimensional diagnostic tasks and lay the groundwork for future deployment of quantum-assisted clinical decision support systems in respiratory healthcare.